Minireview: Regulation of Gene Expression by Nuclear Hormone Receptors

Journal of Receptor and Signal Transduction Research

Volumn 17, Issue 42007, 1997, Pages 319-335

  Meier, Christoph A ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HORMONE RECEPTOR;

CONFERENCE PAPER; DNA DETERMINATION; DNA TRANSCRIPTION; GENE EXPRESSION REGULATION; HORMONE RECEPTOR INTERACTION; HUMAN; NONHUMAN; PROTEIN BINDING; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

GENE EXPRESSION REGULATION; GENETIC DISEASES, INBORN; HORMONE ANTAGONISTS; HUMANS; MODELS, BIOLOGICAL; MODELS, MOLECULAR; NUCLEAR PROTEINS; RECEPTORS, CELL SURFACE;

EID: 0031017097     PISSN: 10799893     EISSN: None     Source Type: Journal    
DOI: 10.3109/10799899709036612     Document Type: Article

References (45)

1. Amero S. A., Kretsinger R. H., Moncrief N. D., Yamamoto K. R., Pearson W. R. The origin of nuclear receptor proteins: A single precursor distinct from other transcription factors. Mol. Endocrinol. 1992; 6: 3 – 7
2. Stunnenberg H. G. Mechanisms of transactivation by retinoic acid receptors. BioEssays 1993; 15: 309 – 315
3. Mangelsdorf D. J., Evans R. M. The RXR heterodimers and orphan receptors. Cell 1995; 83: 841 – 850
4. Bourguet W., Ruff M., Chambon P., Gronemeyer H., Moras D. Crystal structure of the ligand-binding domain of the human nuclear receptor RXR-α. Nature 1995; 375: 377 – 382
5. Renaud J. P., Rochel N., Ruff M., Vivat V., Chambon P., Gronemeyer H., Moras D. Crystal structure of the RAR-gamma ligand-binding domain bound to all-trans retinoic acid. Nature 1995; 378: 681 – 689
6. Wagner R. L., Apriletti J. W., McGrath M. E., West B. L., Baxter J. D., Fletterick R. J. A structural role for hormone in the thyroid hormone receptor. Nature 1995; 378: 690 – 697
7. Smith D. F., Toft D. O. Steroid receptors and their associated proteins. Mol. Endocrinol. 1993; 7: 4 – 10
8. Perlmann T., Vennström B. The sound of silence. Nature 1995; 377: 387 – 388
9. Lee J. W., Ryan F., Swaffield J. C., Johnston S. A., Moore D. D. Interaction of thyroid-hormone receptor with a conserved transcriptional mediator. Nature 1995; 374: 91 – 94
10. Baur E. V., Zechel C., Heery D., Heine M. J. S., Garnier J. M., Vivat V., Le Douarin B., Gronemeyer H., Chambon P., Losson R. Differential ligand-dependent interactions between the AF-2 activating domain of nuclear receptors and the putative transcriptional intermediary factors mSUGl and TIF1. EMBO J. 1996; 15: 110 – 124
11. Cavailles V., Dauvois S., Danielian P. S., Parker M. G. Interaction of proteins with transcriptionally active estrogen receptors. Proc. Natl. Acad. Sci. USA 1994; 91: 10009 – 10013
12. Halachmi S., Marden E., Martin G., MacKay H., Abbondanza C., Brown M. Estrogen receptor-associated proteins: possible mediators of hormone-induced transcription. Science 1994; 264: 1455 – 1458
13. Onate S. A., Tsai S. Y., Tsai M. J., O'Malley B. W. Sequence and characterization of a coactivator for the steroid hormone receptor superfamily. Science 1995; 270: 1354 – 1357
14. Straehle U., Boshart M., Klock G., Stewart F., Schütz G. Glucocorticoid and progesterone-specific effects are determined by differential expression of the respective hormone receptors. Nature 1989; 339: 629 – 632
15. Funder J. W., Pearce P. T., Smith R., Smith A. I. Mineralocorticoid action: Target tissue specificity is enzyme, not receptor, mediated. Science 1988; 242: 583 – 585
16. Umesono K., Murakami K. K., Thompson C. C., Evans R. M. Direct repeats as selective response elements for the thyroid hormone, retinoic acid, and vitamin D3 receptors. Cell 1991; 65: 1255 – 1266
17. Rastinejad F., Perlmann T., Evans R. M., Sigler P. B. Structural determinants of nuclear receptor assembly on DNA direct repeats. Nature 1995; 375: 203 – 211
18. Forman B. M., Umesono K., Chen J., Evans R. M. Unique response pathways are established by allosteric interactions among nuclear hormone receptors. Cell 1995; 81: 541 – 550
19. Yao T. P., Forman B. M., Jiang Z. Y., Cherbas L., Chen J. D., McKeown M., Cherbas P., Evans R. M. Functional ecdysone receptor is the product of EcR and ultraspiracle genes. Nature 1993; 366: 476 – 479
20. Forman B. M., Goode E., Chen J., Oro A. E., Bradley D. J., Perlmann T., Noonan D. J., Burka L. T., McMorris T., Lamph W. W., Evans R. M., Weinberger C. Identification of a nuclear receptor that is activated by farnesol metabolites. Cell 1995; 81: 687 – 693
21. Keller H., Wahli W. Peroxisome proliferator-activated receptors – a link between endocrinology and nutrition. Trends. Endocrinol. Metab. 1993; 4: 291 – 296
22. Green S., Wahli W. Peroxisome proliferator-activated receptors: finding the orphan a home. Mol. Cell. Endocrinol. 1994; 100: 149 – 153
23. Tontonoz P., Hu E., Spiegelman B. M. Regulation of adipocyte gene expression and differentiation by peroxisome proliferator activated receptor gamma. Curr. Opin. Genet. Dev. 1995; 5: 571 – 576
24. Lehmann J. M., Moore L. B., Smith-Oliver T. A., Wilkison W. O., Willson T. M., Kliewer S. A. An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPARgamma). J. Biol. Chem. 1995; 270: 12953 – 12956
25. Kliewer S. A., Lenhard J. M., Willson T. M., Patel I., Morris D. C., Lehmann J. M. A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation. Cell 1995; 83: 813 – 819
26. Forman B. M., Tontonoz P., Chen J., Brun R. P., Spiegelman B. M., Evans R. M. 15-Deoxy-Delta12,14-prostaglandin J2 is a ligand for the adipocyte determination factor PPARgamma. Cell 1995; 83: 803 – 812
27. Spitz I. M., Bardin C. W. Mifepristone (RU 486) – A modulator of progestin and glucocorticoid action. N. Engl. J. Med. 1993; 329: 404 – 412
28. Katzenellenbogen J. A., O'Malley B. W., Katzenellenbogen B. S. Tripartite steroid hormone receptor pharmacology: Interaction with multiple effector sites as a basis for the cell- and promoter-specific action of these hormones. Mol. Endocrinol. 1996; 10: 119 – 131
29. Pfahl M. Nuclear receptor/AP-1 interaction. Endocr. Rev. 1993; 14: 651 – 658
30. Juge-Aubry C. E., Gorla-Bajszczak A., Pernin A., Lemberger T., Wahli W., Burger A., Meier C. A. Peroxisome proliferator-activated receptor mediates cross-talk with thyroid hormone receptor by competition for retinoid X receptor. J. Biol. Chem. 1995; 270: 18117 – 18122
31. Kraus W. L., Weis K. E., Katzenellenbogen B. S. Inhibitory cross-talk between steroid hormone receptors: differential targeting of estrogen receptor in the repression of its transcriptional activity by agonist- and antagonist-occupied progestin receptors. Mol. Cell Biol. 1995; 15: 1847 – 1857
32. Kuiper G. G., Brinkmann A. O. Steroid hormone receptor phosphorylation: is there a physiological role?. Mol. Cell. Endocrinol. 1994; 100: 103 – 107
33. Kato S., Endoh H., Masuhiro Y., Kitamoto T., Uchiyama S., Sasaki H., Masushige S., Gotoh Y., Nishida E., Kawashima H., Metzger D., Chambon P. Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase. Science 1995; 270: 1491 – 1494
34. Quigley C. A., De Bellis A., Marschke K. B., el-Awady M. K., Wilson E. M., French F. S. Androgen receptor defects: historical, clinical, and molecular perspectives. Endocr. Rev. 1995; 16: 271 – 321
35. Smith E. P., Boyd J., Frank G. R., Takahashi H., Cohen R. M., Specker B., Williams T. C., Lubahn D. B., Korach K. S. Estrogen resistance caused by a mutation in the estrogen- receptor gene in a man. N. Engl. J. Med. 1994; 331: 1056 – 1061
36. Meier C. A., Parkison C., Chen A., Ashizawa K., Meier-Heusler S. C., Muchmore P., Cheng S. Y., Weintraub B. D. Interaction of human beta-1 thyroid hormone receptor and its mutants with DNA and retinoid-X receptor-beta: T3 response element dependent dominant negative potency. J. Clin. Invest 1993; 92: 1986 – 1993
37. Yen P. M., Chin W. W. Molecular mechanisms of dominant negative activity by nuclear hormone receptors. Mol. Endocrinol. 1994; 8: 1450 – 1454
38. Taplin M. E., Bubley G. J., Shuster T. D., Frantz M. E., Spooner A. E., Ogata G. K., Keer H. N., Balk S. P. Mutation of the androgen-receptor gene in metastatic androgen-independent prostate cancer [see comments]. N. Engl. J. Med. 1995; 332: 1393 – 1398
39. Visakorpi T., Hyytinen E., Koivisto P., Tanner M., Keinänen R., Palmberg C., Palotie A., Tammela T., Isola J., Kallioniemi O.-P. In vivo amplification of the androgen receptor gene and progression of human prostate cancer. Nature Genet. 1995; 9: 401 – 406
40. Horwitz K. B. How do breast cancers become hormone resistant. J. Steroid Biochem. Mol. Biol. 1994; 49: 295 – 302
41. Mahfoudi A., Roulet E., Dauvois S., Parker M. G., Wahli W. Specific mutations in the estrogen receptor change the properties of antiestrogens to full agonists. Proc. Natl. Acad. Sci. USA 1995; 92: 4206 – 4210
42. Strasser-Wozak E. M., Hattmannstorfer R., Hala M., Hartmann B. L., Fiegl M., Geley S., Kofler R. Splice site mutation in the glucocorticoid receptor gene causes resistance to glucocorticoid-induced apoptosis in a human acute leukemic cell line. Cancer Res. 1995; 55: 348 – 353
43. Agadir A., Cornic M., Gourmel B., Lefebvre P., Degos L., Chomienne C. Review: Retinoic acid receptors: Involvement in acute promyelocytic leukemia. Cell Mol. Biol. 1994; 40: 263 – 274
44. Chen Z., Guidez F., Rousselot P., Agadir A., Chen S. J., Wang Z. Y., Degos L., Zelent A., Waxman S., Chomienne C. PLZF-RAR alpha fusion proteins generated from the variant t(11–17)(q23–q21) translocation in acute promyelocytic leukemia inhibit ligand-dependent transactivation of wild- type retinoic acid receptors. Proc. Natl. Acad. Sci. USA 1994; 91: 1178 – 1182
45. Warrell R. P., Dethe H., Wang Z. Y., Degos L. Acute promyelocytic leukemia. N. Engl. J. Med. 1993; 329: 177 – 189